Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
Clinical trial NCT04743791 · RECRUITING
Trial details
- NCT number
- NCT04743791
- Sponsor
- Sally E. Wenzel MD
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2027-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.